Government orders and lifting of export restrictions benefitted Q2 earnings of Kilpest India. While the near term outlook is positive, our concern lies in the longer-term growth outlook. Majority of current revenue growth is from the Covid-19 test kit orders which would fade eventually. In this edition of Ideas for Profit, we explore if there is an opportunity for investors.
DK Dubey, Director of Kilpest India Ltd, in an interview on CNBC-TV18, talks about the joint venture with Biotools of Spain in the month of September which has now commenced operations.